You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

August 24, 2015

Front-of-Package Labeling in Thailand

Informed Counsel

Expanding waistlines and increasing health awareness have given rise to a consumer culture infatuated with well-being, not only in Thailand but all over the world. For producers, this means intense pressure to create healthy or healthier versions of their products. For the government—specifically the Thai Food and Drug Administration (FDA)—this means an obligation to implement and enforce stricter regulations on food and nutrition.

The Thai Perspective

As we move into an age where life is increasingly fast-paced, there is no reason why the food industry should be left behind. While nutritional labels are often displayed on the back of packaging, Front-of-Package (FOP) labeling has become popular among policy makers because it simplifies the most important information and places it where it is visible at first sight to the hurried consumer. In Thailand, the original 1998 Notification of the Ministry of Public Health (MOPH) implemented non-FOP nutritional labeling requirements which were mandatory for certain foods and voluntary for others. A survey conducted in 2009, however, concluded that the nutritional information was difficult to understand, which caused the FDA to make a number of changes.

In a series of subsequent ministerial notifications, the FDA implemented the Guideline Daily Amount (GDA) system of labeling, an FOP system that made GDA labels mandatory for snack products and certain ready-to-eat foods. The current GDA label breaks down nutritional information into four categories: calories, sugars, fats, and sodium. This requires producers to clearly state the nutrient content and percentage of recommended daily intake per package.

FOP Labeling Around the World

Countries around the world have also introduced policies which mirror the objectives of the GDA system of labeling to help consumers make the “smart” choice quickly. For example, the European Union takes the same approach as Thailand, basing its guidelines on the latest published scientific data on dietary requirements and recommendations. Similarly, the United States uses a voluntary Facts Up Front labeling system, which calls for a summary of calories, saturated fat, sodium, and sugar per serving on the front of various food and beverage products.

Singapore, on the other hand, uses the Healthier Choice Symbol, an interpretive nutrition logo which distinguishes products that are lower in saturated fat and trans fat, sodium, and sugar, but higher in whole grains, fiber, and other healthy nutrients. Nutrition guidelines are set according to each product category. There are 12 main product categories and more than 70 subcategories. In addition, there are variants including the Healthier Snack Symbol and the Healthier Ingredient Symbol.

Australia and New Zealand use the Daily Intake Guide and the Health Star Rating. The Daily Intake Guide is a voluntary scheme which uses a set of reference values for acceptable levels of intake for energy and a variety of nutrients, sugars, protein, fat, fiber, and sodium, to name a few. The Health Star Rating system was developed to make it easier for consumers to compare similarly packaged food and therefore make healthier decisions. It ranks products on a scale from half a star to five stars based on their nutritional profile which includes, for example, energy, saturated fat, and sodium. This system of labeling is a hybrid of the GDA system used by Thailand, the European Union, and the United States, as well as the Healthier Choice Symbol used by Singapore.

The Future of FOP Labeling

The food and beverage community has pushed to revamp the current FOP labeling scheme in Thailand. Currently, the National Food Committee, a subcommittee of the Thai FDA, is working to add to the present FOP GDA labeling scheme, but the additions have yet to be announced. It is known, however, that use of the new FOP label will be voluntary and presently it is only being considered for certain foods. Some organizations are looking for inspiration in the “traffic light” nutritional labeling system, a system that uses the colors red, amber, and green to indicate high, acceptable, and low levels of fat, saturated fats, sugar, and salt in various products. Foods with “green” indicators are healthier than foods with “red” indicators, while foods with “amber” indicators fall in between.

The Federation of Thai Industries Food Group has supported the use of GDA nutrition labels and is determined to become involved in educating consumers about the GDA system of labeling. It prefers the GDA system of labeling to a color-coded system or an interpretive nutritional logo because these are sometimes misleading and vague and often do not comprehensively take into account different nutritional needs.

The good news is that the industry has been invited to participate in the development of a new scheme which producers can both contribute to and benefit from. With the correct industry input, FOP labeling should offer consumers informative nutritional information that is apt for a fast-paced world.

RELATED INSIGHTS​ 

February 26, 2026
Laos’ Food and Drug Department (FDD) has been using a new online registration system for drugs since the beginning of the year. The system, which was implemented following the November 2025 issuance of Notice No. 5960/FDD, became the official pathway for submissions on January 1, 2026. Since that date, paper-based registrations have no longer been accepted. This marks a significant advancement in the digitalization of regulatory processes in Laos. As the online system is now the exclusive platform for registration, renewal, and amendments, companies that have not yet aligned their processes to the new system should act promptly to ensure a smooth transition. To assist with this, the FDD will conduct periodic training sessions on the use of the online registration system, which will be delivered either in person or remotely, depending on operator demand. To start using the system, drug and medical device manufacturers, as well as import-export companies, that have not yet registered must submit a formal request identifying the authorized personnel who will access the platform, after which they will be issued user accounts and access codes. Each request must be accompanied by the company’s enterprise registration certificate (incorporation certificate), a copy of the identity card or passport of each designated user, and a scanned copy of their signature. There is no restriction on the number of users per company, allowing flexibility to meet operational needs. Companies that already hold accounts and access codes from the trial phase may continue using them and may apply for additional accounts if needed. Additional Requirements The new system also introduces a standardized format for drug registration numbers. For example, an import drug registration number such as 06 I 4040/15 will be changed to 06-IM-04040-15, and a domestic drug registration number such as 06 L 4040/15 will be changed to
January 21, 2026
Spurred by global geopolitics and Canada’s Indo-Pacific Strategy, which aims to forge deeper ties with ASEAN, Canadian companies have been showing growing interest in Thailand and Southeast Asia in recent years. To understand the opportunities offered by the region, we sat down with Andrew Stoutley, a Toronto native and the chief operating officer of Tilleke & Gibbins, a leading Southeast Asian regional law firm with over 130 years of history in Thailand. Q: Why are Canadian companies looking at Thailand and Southeast Asia right now? A: Two reasons stand out. First, diversification has moved up the agenda. Many Canadian companies want options outside North America due to tariff volatility and policy uncertainty in the United States, as well as questions around the next Canada–United States–Mexico Agreement mandatory joint review. At the same time, the shift of global production from China to Southeast Asia is accelerating, driven by rising costs, geopolitics, and the need to avoid overreliance on a single market. As a result, Canadian companies are looking for a second production base or a regional hub, and Thailand and its neighbors are natural choices given their manufacturing depth, location, and established supply chains. Second, Canada’s own efforts in the region are gaining traction. The Indo-Pacific Strategy has led to more on-the-ground support, including larger trade missions, upgraded diplomatic posts, and new financing options. Export Development Canada (EDC) now has a presence in Bangkok, giving Canadian companies a direct line to financing and insurance in Thailand. There’s also steady progress on trade frameworks like the recently signed Canada–Indonesia Comprehensive Economic Partnership Agreement (which will come into effect pending domestic procedures), ongoing negotiations of a Canada–ASEAN FTA, and the exciting announcement about the launch of negotiations of a Canada–Thailand FTA. Together, these developments have the potential to make it much easier
January 8, 2026
Thailand’s approach to cannabis regulation has moved quickly from broad access to a medical, prescription‑only system. The latest government regulation classifies the cannabis flower as a controlled herb under the Thai Traditional Medicine Wisdom Act. The latest rules ban advertising and recreational sales, allow sales only to patients with prescriptions (up to 30 days), and require flowers to come from GACP‑certified (Good Agricultural and Collection Practices) farms. More importantly, cannabis dispensaries can only sell to patients presenting valid prescriptions issued by one of seven professions—medical doctors, Thai traditional practitioners, applied Thai traditional practitioners, traditional Chinese medicine practitioners, pharmacists, dentists, and folk healers—consistent with approved clinical indications. Noncompliance risks license suspension or revocation, and criminal penalties of up to one year’s imprisonment or a THB 20,000 fine. The dispensary‑only model that proliferated in Thailand in recent years is expected to end soon, as the rules will push all cannabis dispensaries into medical settings or retail pharmacies. Dispensaries must convert into medical establishments—clinics, pharmacies, or traditional pharmacies—complete with on‑site licensed practitioners as well as budtenders; strong controls for storage, hygiene, odor, and smoke; and facilities for record-keeping. All flowers dispensed or exported must come from GACP‑certified farms. If the government ends dispensaries outright and forces a conversion to clinics or pharmacies, compensation will not be automatic at the outset. As a result, business operators should plan for compliance and repurposing under the Medical Facilities Act, Modern Drug Act, and Herbal Product Act, which regulate medical clinics, modern pharmacies, and traditional medicine pharmacies, respectively. The table below summarizes the required licenses for clinics, pharmacies, and traditional medicine pharmacies selling cannabis flowers in Thailand. Aside from the specific listed licenses, all three types of establishments must also obtain a license to sell a controlled herb (cannabis flowers) from the Department of Thai Traditional
January 6, 2026
On December 30, 2025, Thailand’s Electronic Transactions Development Agency (ETDA) notified digital marketplace operators of a consolidated list of “high‑risk products” that are subject to strict monitoring on digital platforms. The list was jointly prepared by the Thai Industrial Standards Institute (TISI) and the Food and Drug Administration (FDA) to guide platform compliance in the initial phase of implementation of the Electronic Transaction Committee’s Notification on Other Measures for Marketplace for Goods with Specific Characteristics under Section 18(2) of the 2022 Royal Decree on Digital Platform Businesses Requiring Notification B.E.2568 (2025). The notice is addressed to operators of digital platform services that function as product marketplaces with specific characteristics laid out in the notification. The ETDA states that the TISI and the FDA are closely monitoring the high‑risk product categories on digital platforms, and the published list serves as the baseline reference for platform screening during the initial phase of the notification’s implementation. High‑Risk Product List The list aggregates categories of products that are illegal to sell online or are otherwise tightly regulated under Thai law, with an emphasis on health-related products, controlled substances, medical devices, and a wide range of industrial products that require certification or compliance with specified Thai Industrial Standards, as detailed below. Prohibited and tightly controlled health products. This includes all categories of modern medicines subject to control other than general household remedies; all categories of controlled herbal products except for over-the-counter herbal products; narcotics; psychotropic substances; and medical devices requiring use in medical facilities or a physician’s prescription. Selected industrial products requiring heightened controls. The list highlights dozens of TISI-regulated items commonly sold online. Examples include pacifiers, rice cookers, electrical wire, food wrap film, crayons, washing machines and dryers, air conditioners, electric cookers and air fryers, water heaters, microwave ovens, LED luminaires, hair dryers